Xinyou Zhang

No. 1017 Dongmen North Road
Shenzhen, 518020, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Combination of automated sample preparation and micro-flow LC-MS for high-throughput plasma proteomics.

Combination of automated sample preparation and micro-flow LC-MS for high-throughput plasma proteomics.

Journal: Clinical proteomics

Published: July 12, 2022

A global study for acute myeloid leukemia with RARG rearrangement.

A global study for acute myeloid leukemia with RARG rearrangement.

Journal: Blood advances

Published: June 17, 2022

Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer.

Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer.

Journal: Journal of Cancer

Published: August 28, 2019

Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation.

Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation.

Journal: Annals of hematology

Published: August 30, 2018

Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.

Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.

Journal: Journal of cancer research and clinical oncology

Published: August 27, 2018

Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics.

Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics.

Journal: Current medical science

Published: February 25, 2017

HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.

HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.

Journal: Journal of translational medicine

Published: December 13, 2016

Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells.

Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells.

Journal: Journal of cancer research and clinical oncology

Published: November 05, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026